Newsroom
Category
May 26, 2016
A novel antiangiogenic gene therapy, added to another antiangiogenic agent, Avastin (bevacizumab), led to significantly better overall survival (OS) in recurrent glioblastoma multiforme (GBM) compared with historical patients treated with Avastin alone, a small phase 2 trial showed. Read the full story at Cure Today
May 26, 2016
The University of Texas Health Science Center at San Antonio’s Center for Research to Advance Community Health (ReACH) was recognized for its initiative to screen, evaluate and cure chronic hepatitis C. Watch the full story at News 4
May 26, 2016
During a Binational Health Conference, officials from Nuevo Laredo and our city came together to share information. Read the full story at KGNS-TV
May 26, 2016
VeroScience LLC, is pleased to announce that independent research conducted by Dr. Ralph DeFronzo and his team at UT Health Science Center at San Antonio (“Health Science Center“) has continued to delineate metabolic targets of VeroScience’s Cycloset® in reducing hyperglycemia in type 2 diabetes mellitus (T2DM) patients. The study has also identified positive influences of the […]
May 25, 2016
PTSD is shattering the lives of thousands of American soldiers. But some experts believe running can counter the disorder’s debilitating symptoms and help restore the joy that war erased. Read the full story at Runner’s World
May 25, 2016
There could be a new type of treatment for people suffering from post-traumatic stress disorder, according to a researcher at the University of Texas Health Science Center in San Antonio. Read the full story at KSAT 12